2020
· In November 2020, a wholly-owned subsidiary, Jiangsu Deyi Health Management Co., Ltd., was established. · In October 2020, a new product, the Renxian Majing Drug Sky Eye System, was launched. · In October 2020, the Zilan Branch of Jiangsu Renxian Medical Technology Co., Ltd. was established. · In August 2020, it was rated as an advanced unit for "Nantong City's Adverse Drug Reaction Monitoring in 2019". · In March 2020, the Party Branch Committee of Jiangsu Renxian Medical Technology Co., Ltd. was established. · In March 2020, it won the "Outstanding Contribution Award for COVID-19 Prevention and Control" from the Management Committee of Nantong Economic and Technological Development Zone. · In 2020, it participated in the sub-project "Technical Research on Elderly Pain Control" of the National Key R&D Program of Zhongshan Hospital Affiliated to Fudan University. · In 2020, it participated in the sub-project "Research on Technical Measures for the Regulation and Intervention of Elde